134 related articles for article (PubMed ID: 9039540)
1. Successful treatment of severe streptococcal toxic shock syndrome with a combination of intravenous immunoglobulin, dexamethasone and antibiotics.
Chiu CH; Ou JT; Chang KS; Lin TY
Infection; 1997; 25(1):47-8. PubMed ID: 9039540
[No Abstract] [Full Text] [Related]
2. Intravenous immunoglobulin therapy for toxic shock syndrome.
Barry W; Hudgins L; Donta ST; Pesanti EL
JAMA; 1992 Jun; 267(24):3315-6. PubMed ID: 1597914
[TBL] [Abstract][Full Text] [Related]
3. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
Arends JE; Harkisoen S
Clin Infect Dis; 2015 Jan; 60(2):324. PubMed ID: 25313253
[No Abstract] [Full Text] [Related]
5. Group A streptococcal infections. An old adversary reemerging with new tricks?
Feingold DS; Weinberg AN
Arch Dermatol; 1996 Jan; 132(1):67-70. PubMed ID: 8546486
[No Abstract] [Full Text] [Related]
6. Adjunctive treatment of streptococcal toxic shock syndrome using intravenous immunoglobulin: case report and review.
Perez CM; Kubak BM; Cryer HG; Salehmugodam S; Vespa P; Farmer D
Am J Med; 1997 Jan; 102(1):111-3. PubMed ID: 9209207
[No Abstract] [Full Text] [Related]
7. Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome.
Stevens DL
Clin Infect Dis; 1998 Mar; 26(3):639-41. PubMed ID: 9524836
[No Abstract] [Full Text] [Related]
8. Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review.
Cawley MJ; Briggs M; Haith LR; Reilly KJ; Guilday RE; Braxton GR; Patton ML
Pharmacotherapy; 1999 Sep; 19(9):1094-8. PubMed ID: 10610017
[TBL] [Abstract][Full Text] [Related]
9. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
Norrby-Teglund A; Low DE; McGeer A; Kotb M
Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
[No Abstract] [Full Text] [Related]
10. Dilemmas in the treatment of invasive Streptococcus pyogenes infections.
Stevens DL
Clin Infect Dis; 2003 Aug; 37(3):341-3. PubMed ID: 12884157
[No Abstract] [Full Text] [Related]
11. Therapeutic considerations for children with invasive group a streptococcal infections: a case series report and review of the literature.
Burnett AM; Domachowske JB
Clin Pediatr (Phila); 2007 Jul; 46(6):550-5. PubMed ID: 17579110
[No Abstract] [Full Text] [Related]
12. [Beta-hemolytic streptococcal bacteremia in adults].
Rantala S
Duodecim; 2013; 129(14):1477-84. PubMed ID: 23961606
[TBL] [Abstract][Full Text] [Related]
13. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
[TBL] [Abstract][Full Text] [Related]
15. Severe group A streptococcal toxic shock syndrome presenting as primary peritonitis: a case report and brief review of the literature.
Tilanus AM; de Geus HR; Rijnders BJ; Dwarkasing RS; van der Hoven B; Bakker J
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e208-12. PubMed ID: 19914115
[TBL] [Abstract][Full Text] [Related]
16. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses.
Schlievert PM
J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S107-10. PubMed ID: 11586276
[TBL] [Abstract][Full Text] [Related]
17. Reply to Arends and Harkisoen.
Linnér A; Sjölin J; Darenberg J; Henriques-Normark B; Norrby-Teglund A
Clin Infect Dis; 2015 Jan; 60(2):324-5. PubMed ID: 25313251
[No Abstract] [Full Text] [Related]
18. Group B streptococcal necrotizing fasciitis and toxic shock-like syndrome: a case report and review of the literature.
Crum NF; Wallace MR
Scand J Infect Dis; 2003; 35(11-12):878-81. PubMed ID: 14723367
[TBL] [Abstract][Full Text] [Related]
19. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome.
Abinun M; Cant AJ
Lancet; 1994 Jan; 343(8892):300. PubMed ID: 7905129
[No Abstract] [Full Text] [Related]
20. Group A streptococcal meningitis and toxic shock syndrome caused by a protein M type 3 strain producing exotoxin C.
Guibert M; Livartowski J; Brivet F; Galanaud P; Nordmann P
Eur J Clin Microbiol Infect Dis; 1997 Apr; 16(4):323-4. PubMed ID: 9177970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
